Filgrastim is a recombinant human granulocyte colony-stimulating factor (G-CSF). It is commonly used in the management of cancer patients to stimulate the production of white blood cells, particularly neutrophils, which are crucial for fighting infections. The drug is often administered to patients undergoing chemotherapy, which can significantly reduce the number of these essential cells.
